These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3371389)

  • 21. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.
    Head A; Maxwell S; Kendall MJ; Eagles C
    Br J Clin Pharmacol; 1994 Dec; 38(6):499-504. PubMed ID: 7888287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CR.
    Sandberg A; Ragnarsson G; Jonsson UE; Sjögren J
    Eur J Clin Pharmacol; 1988; 33 Suppl():S3-7. PubMed ID: 3371391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
    Grainger SL; John VA; Shotton PA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
    Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary effects of long-term beta 2-blockade in healthy subjects: comparative study of metoprolol OROS.
    Bauer K; Rakusan S; Kaik G
    Am Heart J; 1990 Aug; 120(2):473-7. PubMed ID: 1974382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing.
    Sandberg A; Abrahamsson B; Svenheden A; Olofsson B; Bergstrand R
    Pharm Res; 1993 Jan; 10(1):28-34. PubMed ID: 8430057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
    Löfdahl CG; Dahlöf C; Westergren G; Olofsson B; Svedmyr N
    Eur J Clin Pharmacol; 1988; 33 Suppl():S25-32. PubMed ID: 2836204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
    Agewall S; Kendall M
    J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of a new controlled-release formulation of metoprolol: a comparison with conventional metoprolol tablets in mild to moderate hypertension.
    Houtzagers JJ; Smilde JG; Creytens G; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S39-44. PubMed ID: 3371393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprolol.
    Parker RB; Soberman JE
    Pharmacotherapy; 2011 Jul; 31(7):630-41. PubMed ID: 21923449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers.
    Lundborg P; Abrahamsson B; Wieselgren I; Walter M
    Eur J Clin Pharmacol; 1993; 45(2):161-3. PubMed ID: 8223839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the beta 1-selectivity of conventional metoprolol and metoprolol CR during exercise in healthy volunteers.
    Akhlaghi S; Maxwell SR; Kendall MJ; Hughes B; Greenhaff P
    J Clin Pharm Ther; 1993 Aug; 18(4):259-66. PubMed ID: 8227233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
    Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-related effects of metoprolol on heart rate and pharmacokinetics in heart failure.
    Andersson B; Aberg J; Lindelöw B; Täng MS; Wikstrand J
    J Card Fail; 2001 Dec; 7(4):311-7. PubMed ID: 11782853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.
    Freestone S; Silas JH; Lennard MS; Ramsay LE
    Br J Clin Pharmacol; 1982 Nov; 14(5):713-8. PubMed ID: 7138751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.
    Walle PO; Westergren G; Dimenäs E; Olofsson B; Albrektsen T
    J Clin Pharmacol; 1994 Jul; 34(7):742-7. PubMed ID: 7929868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article.
    Sandberg A; Abrahamsson B; Regårdh CG; Wieselgren I; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S2-16. PubMed ID: 2179280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.
    Fagerberg B; Berglund A; Holme E; Wilhelmsen L; Elmfeldt D
    J Intern Med; 1990 Jan; 227(1):37-43. PubMed ID: 2405089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.